Technical Analysis for KRTX - Karuna Therapeutics, Inc.

Grade Last Price % Change Price Change
D 170.25 1.52% 2.55
KRTX closed up 1.52 percent on Thursday, September 28, 2023, on 1.13 times normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Flat

Date Alert Name Type % Chg
Wide Range Bar Range Expansion 0.00%
Multiple of Ten Bullish Other 0.00%
Outside Day Range Expansion 0.00%
Gapped Up Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Oversold Stochastic Weakness 0.00%
Inside Day Range Contraction 1.52%
Gapped Up Strength 1.52%
Oversold Stochastic Weakness 1.52%
Slingshot Bearish Bearish Swing Setup 1.77%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Reversed from Down about 12 hours ago
Down 1 ATR about 14 hours ago
60 Minute Opening Range Breakdown about 14 hours ago
Outside Day about 14 hours ago
Fell Below Previous Day's Low about 14 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Karuna Therapeutics, Inc. Description

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, primarily focuses on developing novel therapies to address disabling neuropsychiatric conditions characterized by significant unmet medical needs. The company's lead product candidate is KarXT, an oral modulator that is in Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia, as well as in Phase Ib clinical trial for the treatment of central nervous system disorders, such as cognitive and negative symptoms, Alzheimer's, and pain. It also focuses on developing other muscarinic-targeted drug candidates. Karuna Pharmaceuticals, Inc. has a license agreement with Eli Lilly and Company; and patent license agreement with PureTech Health LLC. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was founded in 2009 and is headquartered in Boston, Massachusetts. Karuna Therapeutics, Inc. operates as a subsidiary of PureTech Health plc.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Pain Alzheimer's Disease Schizophrenia Central Nervous System Disorders Nervous System Disorders Treatment Of Central Nervous System Disorders Psychosis Puretech Health

Is KRTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 245.0
52 Week Low 159.73
Average Volume 244,809
200-Day Moving Average 198.04
50-Day Moving Average 182.80
20-Day Moving Average 178.09
10-Day Moving Average 170.45
Average True Range 5.40
RSI (14) 38.65
ADX 31.32
+DI 19.55
-DI 30.63
Chandelier Exit (Long, 3 ATRs) 176.75
Chandelier Exit (Short, 3 ATRs) 178.81
Upper Bollinger Bands 194.99
Lower Bollinger Band 161.20
Percent B (%b) 0.27
BandWidth 18.97
MACD Line -4.83
MACD Signal Line -4.09
MACD Histogram -0.7455
Fundamentals Value
Market Cap 4.56 Billion
Num Shares 26.8 Million
EPS -254.14
Price-to-Earnings (P/E) Ratio -0.67
Price-to-Sales 0.00
Price-to-Book 7.35
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 188.13
Resistance 3 (R3) 187.60 181.11 185.15
Resistance 2 (R2) 181.11 176.56 181.38 184.16
Resistance 1 (R1) 175.68 173.74 172.44 176.21 183.16
Pivot Point 169.19 169.19 167.57 169.46 169.19
Support 1 (S1) 163.76 164.64 160.52 164.29 157.34
Support 2 (S2) 157.27 161.82 157.54 156.34
Support 3 (S3) 151.84 157.27 155.35
Support 4 (S4) 152.37